A$32.48
Fisher-and-Paykel Healthcare Corporation is a medical instruments & supplies business based in Australia. Fisher-and-Paykel Healthcare Corporation shares (FPH) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian dollars. Fisher-and-Paykel Healthcare Corporation has a trailing 12-month revenue of around $1.7 billion. If you're looking to buy shares, check out the steps below.
How to buy shares in Fisher-and-Paykel Healthcare Corporation
To buy shares listed in Australia such as Fisher-and-Paykel Healthcare Corporation, you'll need to sign up to a broker with access to the ASX. Our table can help you compare share trading platforms and choose or you can see our list of the best share trading platforms in Australia. Then follow these steps.
-
Open and fund your brokerage account. Complete an application with your personal and financial details, including your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
-
Search for Fisher-and-Paykel Healthcare Corporation. Find the share by name or ticker symbol: FPH. Research its history to confirm it's a solid investment against your financial goals.
-
Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Fisher-and-Paykel Healthcare Corporation reaches your desired price. Look into dollar-cost averaging to spread out your risk, which smooths out buying at consistent intervals and amounts.
-
Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
-
Check on your investment. Congratulations, you own a part of Fisher-and-Paykel Healthcare Corporation. Optimise your portfolio by tracking how your stock and the business performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that affect your stock.
Our top pick for
AU stocks
Our top pick for
Copy trading
Our top pick for
Mobile app
Fisher-and-Paykel Healthcare Corporation stock price (ASX:FPH)
Use our graph to track the performance of FPH stocks over time.Fisher-and-Paykel Healthcare Corporation shares at a glance
52-week range | $18.2917 - $35.76 |
---|---|
50-day moving average | $31.7668 |
200-day moving average | $26.4113 |
Target price | $25.03 |
PE ratio | 156.2857 |
Dividend yield | $0.415 (1.16%) |
Earnings per share (TTM) | $0.21 |
Where to buy shares
Is it a good time to buy Fisher-and-Paykel Healthcare Corporation stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Fisher-and-Paykel Healthcare Corporation price performance over time
Historical closes compared with the last close of A$32.63
1 week (2024-09-27) | -0.58% |
---|---|
1 month (2024-09-05) | -5.26% |
3 months (2024-07-05) | 19.44% |
6 months (2024-04-05) | 37.56% |
1 year (2023-10-05) | 57.03% |
---|---|
2 years (2022-10-05) | 88.07% |
3 years (2021-10-05) | 11.94% |
5 years (2019-10-04) | 104.32% |
Is Fisher-and-Paykel Healthcare Corporation under- or over-valued?
Valuing Fisher-and-Paykel Healthcare Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Fisher-and-Paykel Healthcare Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Fisher-and-Paykel Healthcare Corporation's P/E ratio
Fisher-and-Paykel Healthcare Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 156x. In other words, Fisher-and-Paykel Healthcare Corporation shares trade at around 156x recent earnings.
That's relatively high compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Fisher-and-Paykel Healthcare Corporation's PEG ratio
Fisher-and-Paykel Healthcare Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 4.4677. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Fisher-and-Paykel Healthcare Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Fisher-and-Paykel Healthcare Corporation's EBITDA
Fisher-and-Paykel Healthcare Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $444.8 million (£0.0 million).
The EBITDA is a measure of a Fisher-and-Paykel Healthcare Corporation's overall financial performance and is widely used to measure stock profitability.
Fisher-and-Paykel Healthcare Corporation financials
Revenue TTM | $1.7 billion |
---|---|
Operating margin TTM | 21.38% |
Gross profit TTM | $938.4 million |
Return on assets TTM | 9.85% |
Return on equity TTM | 7.55% |
Profit margin | 7.61% |
Book value | 3.015 |
Market capitalisation | $19.2 billion |
TTM: trailing 12 months
N/AFisher-and-Paykel Healthcare Corporation share dividends
Dividend payout ratio: 2.1% of net profits
Recently Fisher-and-Paykel Healthcare Corporation has paid out, on average, around 2.1% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.16% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Fisher-and-Paykel Healthcare Corporation shareholders could enjoy a 1.16% return on their shares, in the form of dividend payments. In Fisher-and-Paykel Healthcare Corporation's case, that would currently equate to about A$0.415 per share.
While Fisher-and-Paykel Healthcare Corporation's payout ratio might seem low, this can signify that Fisher-and-Paykel Healthcare Corporation is investing more in its future growth.
The latest dividend was paid out to all shareholders who bought their shares by 25 June 2024 (the "ex-dividend date").
Have Fisher-and-Paykel Healthcare Corporation's shares ever split?
Fisher-and-Paykel Healthcare Corporation's shares were split on a 5:1 basis on 26 September 2004. So if you had owned 1 share the day before the split, the next day you would own 5 shares. This wouldn't directly have changed the overall worth of your Fisher-and-Paykel Healthcare Corporation shares – just the quantity. However, indirectly, the new 80% lower share price could have impacted the market appetite for Fisher-and-Paykel Healthcare Corporation shares which in turn could have impacted Fisher-and-Paykel Healthcare Corporation's share price.
Fisher-and-Paykel Healthcare Corporation share price volatility
Over the last 12 months, Fisher-and-Paykel Healthcare Corporation's shares have ranged in value from as little as $18.2917 up to $35.76. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (AU average) beta is 1, while Fisher-and-Paykel Healthcare Corporation's is 0.419. This would suggest that Fisher-and-Paykel Healthcare Corporation's shares are less volatile than average (for this exchange).
Fisher-and-Paykel Healthcare Corporation overview
Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. It provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company also offers adult respiratory products, including optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation. In addition, it provides infant respiratory products, such as resuscitation, invasive ventilation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products comprising humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, and humidifiers. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.
Fisher-and-Paykel Healthcare Corporation in the news
The Returns On Capital At Fisher & Paykel Healthcare (NZSE:FPH) Don't Inspire Confidence
Investors in Fisher & Paykel Healthcare (NZSE:FPH) have seen notable returns of 99% over the past five years
Fisher & Paykel Healthcare Corp Ltd's Dividend Analysis
Frequently asked questions
More guides on Finder
-
The best day trading platforms in Australia
The best day trading platforms in Australia offer low fees and are packed full of features essential for algorithmic trading.
-
What are the best CHESS-sponsored brokers?
CHESS sponsorship allows you to directly own ASX listed shares in your own name, but it comes with some drawbacks. Find out if it's right for you.
-
The best trading platforms in Australia for beginners
Looking to start investing? Here are our top 6 online trading platforms for total beginners in Australia.
-
What is a joint share trading account?
Considering opening a joint share trading account with your partner? Here is what you need to know
-
Best ASX dividend stocks for 2024
Following a couple of lean years for dividend investors, here are 20 ideas you could consider in your portfolio.
-
How to invest in gold in Australia in 2024
If you’re thinking of investing in gold, our guide will explain how and where to buy gold in Australia as well as the pros and cons of investing in it.
-
The cheapest stock brokers in Australia (Oct 2024)
Find cheap stock brokerage in Australia when buying and selling shares on the ASX and other international exchanges.
-
Best investment accounts in Australia
Looking to build your wealth? A guide on the investment accounts available in Australia.
-
How to open a share trading account
If you're looking to start your investment journey, here's how to open a share trading account.
-
How to buy US stocks from Australia in 2024
Learn how to find the cheapest brokerage fees and a range of flexible trading features when you buy and sell US shares.
Ask a question